No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ADMA ADMA Biologics
- 10.490
- +0.400+3.96%
Close Jun 5 16:00 ET
- 10.431
- -0.059-0.56%
Post 19:56 ET
2.43BMarket Cap-524500P/E (TTM)
10.540High10.060Low3.08MVolume10.180Open10.090Pre Close31.95MTurnover1.36%Turnover RatioLossP/E (Static)231.81MShares10.54052wk High15.82P/B2.38BFloat Cap3.06052wk Low--Dividend TTM227.23MShs Float14.000Historical High--Div YieldTTM4.76%Amplitude1.010Historical Low10.381Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
ADMA Biologics, Inc.'s (NASDAQ:ADMA) Share Price Boosted 53% But Its Business Prospects Need A Lift Too
Despite an already strong run, ADMA Biologics, Inc. (NASDAQ:ADMA) shares have been powering on, with a gain of 53% in the last thirty days.
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
ADMA Biologics First Quarter 2024 Earnings: Beats Expectations
ADMA Biologics Hits 52-week High on Q1 Beat, Guidance Raise
ADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and Earnings Forecasts in Q1 2024
ADMA Biologics Price Target Raised to $10.00/Share From $8.00 by Raymond James
ADMA Biologics Price Target Raised to $10.00/Share From $8.00 by Raymond James
Comments
$ADMA Biologics(ADMA.US$
NEWS
IMPRESSIVE ER
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
ADMA Biologics reported impressive first quarter 2024 financial results, with a total revenue of $81.9 million, a 44% increase year-over-year. The GAAP net income was $17.8 million, a $24.6 million increase year-over-year. Adjusted EBITDA for Q1 2024 was $26.4 million, a 970% increase year-over-year. The company raised its total revenue guidance for FY 2024 to m...
NEWS
IMPRESSIVE ER
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
ADMA Biologics reported impressive first quarter 2024 financial results, with a total revenue of $81.9 million, a 44% increase year-over-year. The GAAP net income was $17.8 million, a $24.6 million increase year-over-year. Adjusted EBITDA for Q1 2024 was $26.4 million, a 970% increase year-over-year. The company raised its total revenue guidance for FY 2024 to m...
$ADMA Biologics(ADMA.US$
$Coinbase(COIN.US$
$Interactive Brokers(IBKR.US$
$Spotify Technology(SPOT.US$
so as much as it sucks apparently reason doesn't win, and here we are about to ban tiktok I guess? because something somethings china-boogeyman. It seems really foolish to upset millions of voters. let alone young voters. and besides their incredibly progressive leanings. I can't imagine what might backfire there.
That said. Between this and the fake news (like actually misinformation/sens...
$Coinbase(COIN.US$
$Interactive Brokers(IBKR.US$
$Spotify Technology(SPOT.US$
so as much as it sucks apparently reason doesn't win, and here we are about to ban tiktok I guess? because something somethings china-boogeyman. It seems really foolish to upset millions of voters. let alone young voters. and besides their incredibly progressive leanings. I can't imagine what might backfire there.
That said. Between this and the fake news (like actually misinformation/sens...
5
$ADMA Biologics(ADMA.US$
This one looks great. Solid fundamentals and technicals. VMACD shows golden cross, but reg macd still hasn't quite yet. Maybe a small dip coming but... worth it.
This one looks great. Solid fundamentals and technicals. VMACD shows golden cross, but reg macd still hasn't quite yet. Maybe a small dip coming but... worth it.
1
3
$ADMA Biologics(ADMA.US$ big pop coming ? 👀
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Ken Griffin Charity : Either you somehow managed to buy in at the absolute lowest back in 2021 and literally never added to your position since then, or you performed a stock transfer and faked the average cost. I suspect it’s the latter
Mr TrecherousOP Ken Griffin Charity:
I Am 102927471 :
Emotionless : Alot of us have low averages. We have been in this along time. Dont be hatin' youd really be hating if i posted up my gains. Just todays for that matter. Good luck to ya theres more to come we just getting the party started. Start opening up them bank accounts your gonna need them. Easy Money.
Ken Griffin Charity Emotionless: Okay show me the gains you made today player. Here, I’ll start with mine:
And btw, I think we both know why you said “just todays for that matter”
View more comments...